Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Ultima Vez Modificado: 5 de abril del 2007
Dear OncoLink "Ask The Experts,"
Can you tell me the current data on the incidence of lymphedema in the legs and genitals following surgery, external and internal radiation and chemotherapy for uterine cancer?
Is there good documentation?
Linda McGrath Boyle PT, DPT CLT-LANA, Cancer Rehab Specialist and OncoLink Lymphedema Team Editor, responds:
In women with stage IB-IIA cervical cancer, the occurrence of lymphedema has been documented from 3-21%. In a recent article by Bergmark et al., published in the International Journal of Gynecological Cancer, 21% of women with stage IB-IIA cervical cancer reported lymphedema symptoms. The women had been treated for cervical cancer with varying treatments, including radical hysterectomy. When compared with population controls (without cancer), they had an 8-fold increase in symptoms indicating lymphedema. Twenty-five percent of these women reported distress due to the lymphedema. Ninety percent of the patients stated they were not willing to trade off survival for freedom from symptoms.
A study in 2003 by Ryan et al. from Australia looked at all types of gynecologic cancers. The diagnosis of lower limb lymphedema was made in 18% of the total sample (490): 53% of these were diagnosed within 3 months of treatment, a further 18% within 6 months, 13% within 12 months, and the remaining 16% up to 5 years following treatment. Women most at risk for developing lymphedema were those who had treatment for vulvar cancer with removal of lymph nodes and follow-up radiotherapy. For this group of women, the prevalence was 47%. In addition, this study determined that many cases occurred within the first year of treatment, which was earlier than previously thought.
Of course, the co morbidities depend upon the stage of the cancer at diagnosis, the surgical approach (i.e. lymphadenectomy), and the radiation dose received. Obesity is also a risk factor for Lymphedema.
This is just a sample of the evidence found in medical literature. You can use PubMed to search for medical literature.
Endocrine System Cancers
Head and Neck Cancers
Urinary Tract Cancers
Bone Marrow Transplants
General Treatment Concerns
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
Cancer Resource List
Resources for Young Adults